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Abstract This study investigates the e¡ect of extracellular an-
nexin I (Anx I) on regulating insulin secretion in isolated rat
pancreatic islets. Results show that Anx I stimulates insulin
release in pancreatic islets regardless of the presence or absence
of extracellular Ca2+. In particular, confocal microscopy shows
that Anx I binds to the surface of islet cells in the absence of
extracellular Ca2+. However, insulin secretion through Anx I
signi¢cantly decreases in trypsin-treated islets. Likewise, there
is minimal binding of Anx I to the surface of trypsin-treated
islets. Anti-Anx I polyclonal antibody also inhibits the stimulat-
ing e¡ect of Anx I on insulin secretion. These results indicate
that Anx I is capable of binding to the cell surface receptor, in
order to regulate the stimulation of insulin release in rat pan-
creatic islets.
( 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Annexin I (Anx I; also called lipocortin I or annexin A1) is
a 37 kDa member of the annexin superfamily, which consists
of at least 13 di¡erent kinds of proteins in the vertebrate.
Annexins can perform reversible Ca2þ-dependent binding to
anionic phospholipids. They are composed of the divergent
N-terminal head domain and the conserved C-terminal core
domain. The core structure consists of either four or eight
repeats of a conserved 70 amino acid unit [1^3]. Likewise,
annexins have been reported to in£uence various intracellular
processes in several cells and tissues such as exocytosis [4^6],
membrane tra⁄cking [7], endocytosis [8,9], and anti-in£am-
mation [10^12].
Various annexins play a regulatory role in the exocytosis of
secretory vesicles in adrenal chroma⁄n cells [5], anterior pi-
tuitary cells [6], and pancreatic L-cells [13^15]. Studies have
shown that intracellular annexins play a role in the regulation
of insulin secretion in pancreatic L-cells. In particular, Anx I
is localized in insulin-containing vesicles. It may be involved
in the regulatory mechanism of glucose-induced insulin secre-
tion via the protein phosphorylation process [13]. On the oth-
er hand, the literature suggests that annexin VII may be in-
volved in glucose-induced insulin secretion via Ca2þ signaling
through IP3 receptors [14]. Likewise, annexin XI is concen-
trated in insulin-containing vesicles. It may function in Ca2þ-
and GTP-QS-dependent insulin release via the mediating mem-
brane fusion [15]. However, the regulatory mechanisms of
annexins on the secretory machinery have yet to be fully ex-
plained.
Recent studies on the di¡erent types of cells have shown
that annexins are translocated to the outer cell surface
[11,16,17]. Moreover, Anx I binds to binding sites on the sur-
face of the cells. It performs speci¢c physiological functions in
blood cells [18,19], ¢broblast-like synoviocytes [12], or anteri-
or pituitary cells [20,21]. These reports served as the basis of
this study, i.e. whether pancreatic islet cells have surface bind-
ing sites for Anx I-mediated insulin secretion.
Speci¢cally, this study demonstrates the stimulating e¡ect
of exogenous Anx I on insulin secretion in rat pancreatic islets
for the ¢rst time. Likewise, biochemical and confocal imaging
approaches reveal the involvement of Anx I receptors in in-
sulin secretion.
2. Materials and methods
2.1. Puri¢cation of human recombinant Anx I
Human recombinant Anx I was overexpressed in the Escherichia
coli strain C600 harboring pHT1 [23], which was kindly donated by
Dr. Doe Sun Na, College of Medicine, University of Ulsan, South
Korea. Recombinant Anx I in the soluble fraction of bacterial cells
[23] was puri¢ed as previously described [24] with some modi¢cations.
Puri¢ed Anx I was separated on 12% gel using SDS^PAGE and a
single 37 kDa band was detected by protein staining with Coomassie
brilliant blue R-250 (Sigma) and Western blotting with anti-Anx I
monoclonal antibody (mAb) (Transduction). Puri¢ed Anx I was
used for all subsequent experiments.
2.2. Isolation of rat pancreatic islets
Islets were isolated from pancreases of male Sprague^Dawley rats
(8 weeks old) under aseptic conditions using collagenase digestion [25]
and Ficoll density gradient [26] methods. Isolated pancreatic islets
were incubated in RPMI 1640 medium supplemented with 10% fetal
bovine serum (Gibco BRL), 100 U/ml penicillin, 0.1 mg/ml strepto-
mycin, and 5.6 mM D-glucose at 37‡C under 5% CO2 for 16^18 h [27].
Cultured islets were suspended in Krebs^Ringer bicarbonate HEPES
bu¡er (KRBH, pH 7.4) and used for experiments [28]. All other tissue
culture reagents were purchased from Sigma.
2.3. Measurement of insulin secreted into medium
The amount of insulin secreted into medium from islets was mea-
sured by ELISA (enzyme-linked immunosorbent assay) in triplicate as
described in [29]. First, the 96-well plates were coated with the 1:1000
diluted rabbit anti-guinea pig IgG (Sigma) in the carbonate^bicarbon-
ate bu¡er (50 mM, pH 9.6). The plates were washed with phosphate-
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bu¡ered saline (PBS) (pH 7.2) containing 0.05% Tween 20 and incu-
bated with the 1:10 000 diluted anti-insulin polyclonal antibody
(Dako) in the phosphate bu¡er (40 mM, pH 7.4) containing 0.1%
bovine serum albumin (BSA). After washing the plates, the standards
or the samples diluted with PBS (pH 7.2) containing 6% BSA were
added to the plates and incubated at 4‡C overnight. The peroxidase-
conjugated insulin (2.5 mU/ml) (Sigma) was added to each well and
incubated to assay the free residual antibody-binding activity in the
mixture. The absorbance of developed reactions was read at 490 nm
after 15 min at 37‡C from the addition of o-phenylenediamine. All
other incubation steps were carried out at 37‡C for 2 h. Bovine insulin
(RIA grade from Sigma) was used as the standard.
2.4. Analysis of the surface binding sites of Anx I by laser scanning
confocal microscopy
Fluorescence labeling was performed using £uorescein isothiocya-
nate (FITC; Sigma) as described in [17]. Anx I or BSA (2 mg) was
incubated in 1 ml of coupling bu¡er (50 mM bicarbonate, pH 8.5)
containing 0.1 mg of FITC with slow stirring for 2 h at 4‡C in the
dark for the conjugation of FITC. FITC-conjugated Anx I and FITC-
conjugated BSA were separated from free FITC by dialysis in PBS.
For the analysis of the surface binding sites of Anx I, isolated islets
were incubated in KRBH (pH 7.4) or KRBH containing trypsin (0.3
Wg/ml) at 37‡C for 5 min and washed with KRBH. Washed islets were
incubated in KRBH containing 1 WM of FITC-conjugated BSA or
1 WM of FITC-conjugated Anx I at 37‡C for 1 h. Islet cells were ¢xed
with 2% of paraformaldehyde dissolved in PBS. The ¢xed islet cells
were washed, resuspended in PBS, and transferred to a glass slide
together with antifade [30]. The images were acquired through a Zeiss
LSM 510 laser scanning confocal microscope.
2.5. Detection of Anx I secreted into medium
Isolated islets (200 islets) were incubated in 0.5 ml of KRBH (pH
7.4) in the presence or absence of 20 mM glucose at 37‡C for 60 min.
After discarding islets by centrifugation, 0.1 ml of medium was used
to measure the amount of insulin and 0.4 ml of medium was concen-
trated by adding 0.4 ml of 20% cold trichloroacetic acid (TCA). Sam-
ples were centrifuged at 10 000Ug for 15 min. The precipitates were
washed with ethanol:ether (1:1, v/v) three times. Concentrated sam-
ples were separated on 12% gel using SDS^PAGE for Western blot-
ting with anti-Anx I mAb.
2.6. Statistical analysis
Data were presented as the meanSS.E.M. and statistical signi¢-
cance was analyzed by one-way analysis of variance (ANOVA) or
Student’s t-test. In all cases P6 0.05 was taken as signi¢cant.
3. Results
3.1. Anx I stimulates insulin secretion from rat pancreatic islets
The role of intracellular annexins in insulin secretion has
been reported in rat pancreatic islets [13^15]. Likewise, the
presence of Anx I surface binding sites has been demonstrated
in several cell types [12,19,21]. Thus, we sought to investigate
the external e¡ect of Anx I on insulin secretion in rat pancre-
atic islets. Isolated islets were incubated in KRBH (pH 7.4)
containing varying concentrations of Anx I in the presence or
absence of 0.1 mM Ca2þ. Surprisingly, results showed that
exogenous Anx I prominently enhanced insulin release in pan-
creatic islets. In addition, the stimulating e¡ect of Anx I was
the same regardless of the presence or absence of extracellular
Ca2þ (Fig. 1). These results suggested that Anx I binding sites
might exist on the surface of islet cells and they might be
protein receptors.
3.2. Inhibitory e¡ects of trypsin treatment and anti-Anx I
polyclonal antibody (pAb) on Anx I-stimulated insulin
secretion
To characterize the property of Anx I binding sites, rat
pancreatic islets were incubated in KRBH (pH 7.4) containing
varying concentrations of trypsin. They were then washed and
treated with Anx I to determine whether a trypsin-sensitive
receptor was involved in the binding of Anx I to mediate
insulin secretion. As expected, the e¡ect of Anx I on insulin
secretion was signi¢cantly decreased in pancreatic islets
treated with trypsin on a dose-dependent basis (Fig. 2).
On the other hand, rat pancreatic islets were treated with
anti-Anx I pAb and Anx I solution to inhibit the binding of
Anx I to the cell surface receptor. Similarly, anti-Anx I pAb
inhibited the Anx I-stimulated insulin secretion on a dose-de-
pendent basis (Fig. 3).
3.3. Anx I binds to the surface of islet cells
To further con¢rm the existence and the property of the
surface receptor of Anx I, isolated pancreatic islets were
treated with FITC-conjugated BSA or FITC-conjugated
Anx I. Trypsin-treated islets were also treated with FITC-con-
jugated Anx I. The specimens were then examined under con-
focal microscopy. In the control, the £uorescence was minimal
(Fig. 4A). In contrast, in the samples treated with FITC-con-
jugated Anx I, the £uorescence image showed that Anx I
bound to the peripheries of islet cells (Fig. 4C). However,
the £uorescence image of the trypsin-treated islets showed
that trypsin treatment signi¢cantly eliminated the £uorescence
on the peripheries of islet cells (Fig. 4E).
3.4. Glucose causes the secretion of Anx I from pancreatic
islets
Results obtained from this study gave rise to the problem of
whether Anx I would be secreted to the outside of islet cells to
bind to the surface binding sites, hence necessitating the de-
tection of Anx I secreted to the outside of islets. Results
showed that 20 mM glucose increased not only insulin release
but also Anx I secretion to the extracellular space of islet cells
(Fig. 5).
Fig. 1. E¡ect of Anx I on insulin secretion from rat pancreatic is-
lets. Isolated islets (20 islets/well) were incubated in KRBH (pH 7.4)
containing varying concentrations of Anx I in the presence (black)
or absence (white) of 0.1 mM Ca2þ at 37‡C for 90 min. The
amount of insulin secreted into medium was measured by ELISA.
Results are meansSS.E.M. from four independent experiments.
Each experiment was conducted in triplicate. Ps 0.05 presence of
0.1 mM Ca2þ versus absence of Ca2þ (ANOVA). P6 0.05 control
(no Anx I-treated) versus Anx I-treated in the presence (black) or
absence (white) of 0.1 mM Ca2þ (ANOVA).
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4. Discussion
This study presented experimental evidence that extracellu-
lar Anx I stimulated insulin secretion by binding to a putative
cell surface receptor in rat pancreatic islets. While Anx I has
been reported to function via cell surface receptors in other
cell types [12,19,21], this is the ¢rst report on the function of
Anx I surface binding sites in pancreatic islet cells to date.
The exogenous Anx I was demonstrated to stimulate insulin
secretion in pancreatic islets in a Ca2þ-independent manner
(Fig. 1). Annexins are considered to bind in a Ca2þ-dependent
manner to anionic phospholipids of membranes for most of
their physiological roles [1,2]. Likewise, Anx I-stimulated in-
sulin secretion signi¢cantly decreased in islets treated with
trypsin (Fig. 2), suggesting that binding sites might be a mem-
brane protein. The high ratio of anti-Anx I pAb to Anx I
(4:1) completely blocked the response of Anx I-stimulated
insulin secretion (Fig. 3). These observations suggest that
extracellular Anx I may mediate insulin secretion via a protein
receptor in islet cells. Although Ca2þ-independent phospho-
lipid binding properties of annexins have been reported in
recent years, a low pH is required for Ca2þ-independent phos-
pholipid binding [3]. However, our experiments were con-
ducted at pH 7.4.
Recent studies suggest that intracellular annexins may be
Fig. 2. E¡ect of Anx I on insulin secretion from pancreatic islets
treated with trypsin. Isolated islets (20 islets/well) were treated with
varying concentrations of trypsin at 37‡C for 5 min, washed, and
incubated in KRBH (pH 7.4) containing 1 WM Anx I at 37‡C for
90 min. The amount of insulin secreted into medium was measured
by ELISA and presented as percentages of the control, which was
treated with bu¡er instead of trypsin. Results are meansSS.E.M.
from three independent experiments. Each experiment was con-
ducted in triplicate. The average of controls was 5.8 S 0.9 ng
(meanSS.E.M.). P6 0.05 control (no trypsin-treated) versus tryp-
sin-treated (t-test).
Fig. 3. Inhibition of Anx I-induced insulin secretion from pancreatic
islets by anti-Anx I antibody. Isolated islets (20 islets/well) were in-
cubated in KRBH (pH 7.4) containing anti-Anx I pAb and Anx I,
which were premixed at various ratios, at 37‡C for 90 min. The
amount of insulin secreted into medium was measured by ELISA
and presented as percentages of the control, which was treated with
only Anx I. Results are meansSS.E.M. from three independent ex-
periments. Each experiment was conducted in triplicate. The average
of controls was 6.5S 0.7 ng (meanSS.E.M.). P6 0.05 control (only
Anx I-treated) versus IgG-treated (t-test).
Fig. 4. Binding of Anx I to the surface of pancreatic islet cells. Iso-
lated islets were incubated in KRBH (A,B and C,D) or KRBH con-
taining trypsin (0.3 Wg/ml) (E,F) at 37‡C for 5 min and washed with
KRBH. Each sample was incubated with 1 WM of FITC-conjugated
BSA (A,B) or 1 WM of FITC-conjugated Anx I (C,D and E,F) at
37‡C for 60 min, washed with KRBH, ¢xed with 2% paraformalde-
hyde, and transferred to the slide glass. Stained samples were exam-
ined with a Zeiss LSM 510 confocal microscope (U650). Panels A,
C, and E represent £uorescence images; panels B, D, and F repre-
sent phase contrast images.
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involved in regulating insulin secretion in islet cells, since an-
nexins increase with insulin secretion due to the high concen-
tration of glucose or Ca2þ [13,15]. However, results obtained
in the present study do not discount the involvement of intra-
cellular annexins in the regulatory mechanism of insulin se-
cretion in islet cells ; rather, they suggest that Anx I may have
dual functions on insulin secretion in pancreatic islets, due to
the pleiotropic physiological e¡ects of most annexins.
Fluorescence induced by the binding of FITC-conjugated
Anx I to the peripheries of islet cells and its elimination by
trypsin treatment (Fig. 4C and 4E) indicate that extracellular
Anx I binds to a protein receptor on the cell surface. In
addition, extracellular Anx I was detected by anti-Anx I
mAb on the outside of the islet cells (Fig. 5). Immunoelectron
microscopy studies have shown that annexins are localized on
insulin-containing vesicles [13^15]. Although it is still un-
known whether secretion of annexins can occur, intracellular
annexins are reportedly released to the outer cell surface and
extracellular annexin activities have recently been described
[3,6,11,16,31,32]. Thus, Anx I is probably secreted from the
islet cells during exocytosis of the insulin-containing vesicles.
These results suggest that Anx I probably acts as an autocrine
signal to stimulate insulin secretion in pancreatic islets.
In conclusion, the present study suggests that Anx I may
play a role as an extracellular signal via the surface receptor
of islet cells, in order to initiate the signal transduction path-
way for insulin secretion.
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Fig. 5. Secretion of insulin and Anx I from pancreatic islets by glu-
cose. Isolated islets (200 islets) were incubated in 0.5 ml of KRBH
(pH 7.4) in the presence or absence of 20 mM glucose at 37‡C for
60 min. Secreted Anx I was concentrated by TCA precipitation and
a single Anx I band was detected by Western blot analysis using
anti-Anx I mAb. The amount of insulin secreted into medium was
measured by ELISA. Results are meansSS.E.M. from three inde-
pendent experiments. Each experiment was conducted in triplicate.
P6 0.05 control versus 20 mM glucose (t-test).
FEBS 26733 19-11-02 Cyaan Magenta Geel Zwart
S.-H. Hong et al./FEBS Letters 532 (2002) 17^2020
